SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-447080
Filing Date
2013-11-19
Accepted
2013-11-19 17:26:08
Documents
10
Period of Report
2013-11-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d627388d8k.htm 8-K 62139
2 EX-2.1 d627388dex21.htm EX-2.1 345292
3 EX-4.1 d627388dex41.htm EX-4.1 84026
4 EX-10.1 d627388dex101.htm EX-10.1 345010
5 EX-10.2 d627388dex102.htm EX-10.2 309174
6 EX-23.1 d627388dex231.htm EX-23.1 1839
7 EX-99.1 d627388dex991.htm EX-99.1 336172
8 EX-99.2 d627388dex992.htm EX-99.2 115713
9 GRAPHIC g627388img01.jpg GRAPHIC 12326
10 GRAPHIC g627388img02.jpg GRAPHIC 14267
  Complete submission text file 0001193125-13-447080.txt   1637554
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35347 | Film No.: 131230943
SIC: 2834 Pharmaceutical Preparations